Lavaca Capital’s Medtronic MDT Stock Holding History

Lavaca Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.1K	Hold	500	–	–	﹤0.01%	225
2026 Q1	$43.3K	Sell	500 -192	-28%	-$18.4K	0.01%	180
2025 Q4	$66.5K	Hold	692	–	–	0.01%	146
2025 Q3	$65.9K	Hold	692	–	–	0.01%	146
2025 Q2	$60.3K	Buy	692 +200	+41%	+$17K	0.02%	152
2025 Q1	$44.2K	Hold	492	–	–	0.02%	159
2024 Q4	$39.3K	Buy	+492	New	+$42.6K	0.02%	200
2023 Q3	–	Sell	-5,260	Closed	-$463K	–	151
2023 Q2	$463K	Buy	+5,260	New	+$453K	0.14%	111
2019 Q1	–	Sell	-217	Closed	-$20K	–	400
2018 Q4	$20K	Buy	+217	New	+$20.3K	0.02%	185

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Lavaca Capital's MDT Position: Q2 2026 in Review

Lavaca Capital held its Medtronic (MDT) position steady in Q2 2026 at 500 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #225.

Lavaca Capital first reported a position in MDT in Q4 2018 and has held it in 9 quarters since. The position peaked at $463K in Q2 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Lavaca Capital held 500 shares of Medtronic worth $39.1K as of Q2 2026.
Lavaca Capital left its Medtronic share count unchanged in Q2 2026.
Medtronic made up ﹤0.01% of Lavaca Capital's portfolio in Q2 2026, its #225 holding.
Lavaca Capital first reported a position in Medtronic in Q4 2018 and has held it in 9 quarters since.
Lavaca Capital's Medtronic position peaked at $463K in Q2 2023.
2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.